Cargando…
The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058617/ https://www.ncbi.nlm.nih.gov/pubmed/32296041 http://dx.doi.org/10.1038/s41392-020-0121-2 |
_version_ | 1783503892380647424 |
---|---|
author | Shi, Rui Chai, Yan Duan, Xiaomin Bi, Xiaoshan Huang, Qingrui Wang, Qihui Tan, Shuguang Gao, George F. Zhu, Jianhua Yan, Jinghua |
author_facet | Shi, Rui Chai, Yan Duan, Xiaomin Bi, Xiaoshan Huang, Qingrui Wang, Qihui Tan, Shuguang Gao, George F. Zhu, Jianhua Yan, Jinghua |
author_sort | Shi, Rui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7058617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70586172020-03-19 The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination Shi, Rui Chai, Yan Duan, Xiaomin Bi, Xiaoshan Huang, Qingrui Wang, Qihui Tan, Shuguang Gao, George F. Zhu, Jianhua Yan, Jinghua Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-03-06 /pmc/articles/PMC7058617/ /pubmed/32296041 http://dx.doi.org/10.1038/s41392-020-0121-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter Shi, Rui Chai, Yan Duan, Xiaomin Bi, Xiaoshan Huang, Qingrui Wang, Qihui Tan, Shuguang Gao, George F. Zhu, Jianhua Yan, Jinghua The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination |
title | The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination |
title_full | The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination |
title_fullStr | The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination |
title_full_unstemmed | The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination |
title_short | The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination |
title_sort | identification of a cd47-blocking “hotspot” and design of a cd47/pd-l1 dual-specific antibody with limited hemagglutination |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058617/ https://www.ncbi.nlm.nih.gov/pubmed/32296041 http://dx.doi.org/10.1038/s41392-020-0121-2 |
work_keys_str_mv | AT shirui theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT chaiyan theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT duanxiaomin theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT bixiaoshan theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT huangqingrui theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT wangqihui theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT tanshuguang theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT gaogeorgef theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT zhujianhua theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT yanjinghua theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT shirui identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT chaiyan identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT duanxiaomin identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT bixiaoshan identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT huangqingrui identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT wangqihui identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT tanshuguang identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT gaogeorgef identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT zhujianhua identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination AT yanjinghua identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination |